Enorama Pharma

On 7 April 2026, an extraordinary general meeting and first control meeting was held in Enorama Pharma AB (publ), reg. no. 556716-5591 ("Enorama Pharma" or the "Company"). Below is a summary of the resolution that was passed.

Resolution on continuing the Company's operations

The general meeting resolved, in accordance with the board of directors' primary proposal, that the Company shall continue its operations and not go into liquidation.

The board of directors considers that the discussions regarding the injection of capital and various capital raising measures from existing and new investors will enable the Company's equity to be restored within the time prescribed by the Swedish Companies Act (Sw. aktiebolagslagen) (8 months).

The resolution means that the Company shall convene a new general meeting within eight months from today's date in order to, at a second control meeting, reconsider the issue of Enorama Pharma going into liquidation. Prior to the second control meeting, the board of directors will prepare a new balance sheet for liquidation purposes and have it reviewed by the Company's auditor. If the capital has not been restored to at least the registered share capital, the Company is obliged to enter into liquidation.

The board of directors had also prepared a secondary proposal for a resolution on liquidation in accordance with the Swedish Companies Act (Sw. aktiebolagslagen). However, this proposal was not considered since the general meeting resolved to continue the operations.

CONTACT

Enorama Pharma AB (publ)

Bengt Jönsson, CEO

info@enorama.se

Strandvägen 7A, 114 51 Stockholm

www.enorama.se

Enorama Pharma AB (publ) is listed on Nasdaq First North Growth Market.

The Company's Certified Adviser is Tapper Partners AB, +46 (0)70 44 010 98, ca@tapperpartners.se.

ABOUT ENORAMA PHARMA

Enorama Pharma's vision is to be a leading global manufacturer and supplier of consumer-friendly, oral nicotine products. The Company intends to expand through product and brand development and by establishing strategically important partnerships. For more information, visit www.enorama.se.